rs1555439526
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_001271.4(CHD2):c.878G>A(p.Ser293Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001271.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHD2 | NM_001271.4 | c.878G>A | p.Ser293Asn | missense_variant | 9/39 | ENST00000394196.9 | NP_001262.3 | |
CHD2 | NM_001042572.3 | c.878G>A | p.Ser293Asn | missense_variant | 9/13 | NP_001036037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD2 | ENST00000394196.9 | c.878G>A | p.Ser293Asn | missense_variant | 9/39 | 5 | NM_001271.4 | ENSP00000377747 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461770Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727170
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy 94 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 29, 2023 | This variant has not been reported in the literature in individuals affected with CHD2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 293 of the CHD2 protein (p.Ser293Asn). ClinVar contains an entry for this variant (Variation ID: 474399). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CHD2 protein function. - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jan 23, 2020 | The c.878G>A (p.Ser293Asn) variant substitutes a highly conserved Serine for Asparagine at amino acid 293/1829 (coding exon 9/39).This variant is absent from gnomAD suggesting it is not a common benign variant in the populations represented in this database. In silicoalgorithms predict this variant to be Neutral (Provean; score: 2.83) and Tolerated (SIFT; score: 1.000) to the function of the canonical transcript. This variant is reported as a Variant of Uncertain Significance in ClinVar (VarID: 474399), and to our current knowledge has not been reported in affected individuals in the literature. The p.Ser293 residue is within the first Chromodomainof CHD2 which is thought to be involved in chromatin remodeling activity [PMID: 25384982]. Given the lack of compelling evidence for its pathogenicity, the c.878G>A (p.Ser293Asn) variant is reported here as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at